COVID-19 @ NIBIB

NIBIB's goal is to accelerate research, translation, and commercialization of technologies that will provide solutions to the COVID-19 pandemic.

NIBIB is administering the RADx℠ Tech and Advanced Technology Platforms (ATP) programs. These programs are part of the NIH RADx℠ Initiative to increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID. In addition, NIBIB is supporting other technology development, imaging approaches, and digital platforms to address the pandemic.

Rapid Acceleration of Diagnostics (RADx℠) Tech and ATP Programs

Liberty 16

The RADx Tech and ATP programs are supporting late-stage development of innovative point-of-care, home-based tests, and clinical laboratory tests.

generic bar chart titled tests produced

Summary data on proposals submitted to the RADx℠ Tech and ATP Programs.

RADx Testing

Descriptions of innovative point of care, home-based, improved clinical laboratory tests, and testing products that are increasing the capacity of testing in the U.S.

COVID-19 Research across NIBIB

Intramural Research on COVID-19

NIBIB’s Dr. Kaitlyn Sadtler is a study lead and Principal Investigator working with NIH colleagues to test people who were infected with SARS-CoV-2 and developed antibodies but did not develop symptoms. Read more about the study.

MRI of chest with arrows pointing to points on the lungs

Learn how this collaborative network is using medical imaging and clinical data sciences to reveal unique features of COVID-19. Learn more about the project.

Videos

View videos about RADx Tech/ATP programs, interviews with the NIBIB Director and more.

Program Contacts

RADxSM Tech/ATP programmatic or technical inquiries: info.radx@poctrn.org

All other RADxSM Tech/ATP Applicants: RADxNIBIB@mail.nih.gov

SBIR/STTR Applicants: NIBIB-SBIR@mail.nih.gov

All others: COVID19NIBIB@nibib.gov

Related Resources

NIH COVID-19 website

NIBIB announces additional RADx Tech program Phase 2 awards

Learn about clinical trials for treatments and vaccines at HHS Combat COVID

Director’s Message on COVID-19

NIH COVID-19 Information for Applicants/Grantees

Media Inquiries: nibibpress@mail.nih.gov or 301-496-3500

Related News

View All News
NIH to evaluate COVID-19 at-home testing system
Press Releases
March 1, 2021
diagnostic test in a box
An NIH-funded research team has launched a study to assess performance and usability of a smartphone app paired with the Quidel QuickVue At-Home COVID-19 Test, which received FDA emergency use authorization for use with a prescription.
Mass General-MIT Team Create an Online COVID-19 Testing Calculator for Schools and Businesses
NIBIB in the News
February 18, 2021
While the progress toward widespread COVID-19 vaccination is encouraging, testing, masking, social distancing, contact tracing and isolation will continue to play a key role in limiting outbreaks and keeping schools and businesses open. Source: BENCH press
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing
NIBIB in the News
February 17, 2021
The final RADx portfolio of products to be developed and scaled includes a diversity of diagnostics from companies such as Illumina, Quidel, Fluidigm, and Mesa Biotech, and is likely to result in a near-term manufacturing boom in rapid antigen tests and over-the-counter home-use diagnostics. Source: genomeweb.
DOD Awards $231.8 Million Contract to Ellume USA LLC to Increase Domestic Production Capacity and Deliver COVID-19 Home Tests
NIBIB in the News
February 1, 2021
The DOD, in coordination with the Department of Health and Human Services, awarded $231.8 million to Ellume USA LLC to onshore production capacity of the Ellume COVID-19 Home Test for the United States. Read more at the Department of Defense website.
NIBIB-funded collaboration launches its first set of COVID-19 medical images
Science Highlights
January 19, 2021
CT chest and coronavirus
The Medical Imaging and Data Resource Center (MIDRC), a collaboration of leading medical imaging organizations funded by NIBIB, has launched a repository of imaging data to facilitate medical imaging research on COVID-19.